PFIZER INC — Director's Dealing 2020

Feb 29, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2020-02-26

Reporting Person: YOUNG JOHN D (Group President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-26	Common Stock	M	144928.0000	$34.5900	Acquired	503738.0000	Direct
2020-02-26	Common Stock	A	45566.0000	$0.0000	Acquired	549304.0000	Direct
2020-02-26	Common Stock	F	12485.0000	$34.7200	Disposed	536819.0000	Direct
2020-02-26	Common Stock	F	22314.0000	$34.7200	Disposed	514505.0000	Direct
2020-02-26	Common Stock	F	110626.0000	$36.8000	Disposed	403879.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-26	Stock Appreciation Rights	$34.5900	M	144928.0000	Disposed	2020-02-26	Common Stock (144928.0000)	Direct
2020-02-27	Stock Appreciation Rights	$34.1000	A	170368.0000	Acquired	2025-02-27	Common Stock (170368.0000)	Direct
2020-02-27	Stock Appreciation Rights	$34.1000	A	145969.0000	Acquired	2027-02-27	Common Stock (145969.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2154.0000	Indirect
Common Stock	1522.0000	Indirect

Footnotes

F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).

F2: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).

F3: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.

F4: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).

F5: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).

F6: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

F7: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

F8: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.